» Articles » PMID: 22127554

Leptin, Adiponectin and Vascular Stiffness Parameters in Women with Systemic Lupus Erythematosus

Overview
Publisher Springer
Date 2011 Dec 1
PMID 22127554
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of the present study was to determine levels of adipokines and their relationship with stiffness parameters and disease activity index in SLE patients in comparison with healthy controls. Sixty SLE patients and 29 control subjects were enrolled in the study. Serum leptin and adiponectin levels were determined by commercial sandwich ELISA kits. Colour-coded carotid duplex sonography was performed using a Siemens SONOLINE Antares machine equipped with linear 5-13 MHz. SLEDAI, ECLAM and SLICC were evaluated in all patients. Data were analysed by software for statistical analysis (Prism 5.0). Median leptin is higher among SLE patients compared with controls (p 0.035). Median values of vascular stiffness and PSEM are increased in SLE compared with controls (p = 0.0003 and p = 0.007). Vascular strain and vascular distensibility are lower in SLE patients in comparison with controls (p = 0.0001 and p = 0.0006, respectively). Considering SLE patients, leptin levels correlate with vascular stiffness (r = 0.64, p < 0.0001) and PSEM (r = 0.63, p < 0.0001). Adiponectin levels correlate with vascular strain (r = 0.28, p 0.039) and negatively correlate with vascular stiffness (r = -0.38, p 0.039). Leptin levels correlate with disease activity (SLEDAI and ECLAM) and cumulative damage (SLICC) indexes. This study demonstrates higher values of leptin in SLE patients. Moreover, SLE patients show increased levels of vascular stiffness and PSEM and reduced values of vascular strain and distensibility. These results globally indicate a decline in arterial elasticity. We find a positive correlation of leptin with stiffness parameters. According to its atheroprotective action, adiponectin inversely correlates with stiffness parameters.

Citing Articles

Leptin antagonism attenuates hypertension and renal injury in an experimental model of autoimmune disease.

Kalusche W, Case C, Taylor E Clin Sci (Lond). 2023; 137(23):1771-1785.

PMID: 38031726 PMC: 10721433. DOI: 10.1042/CS20230924.


High serum leptin and adiponectin levels as biomarkers of disease progression in Egyptian patients with active systemic lupus erythematosus.

Kamel S, Abdel Azeem Abd Elazeem M, Mohamed R, Kamel M, Abdel Aleem Abdelaleem E Int J Immunopathol Pharmacol. 2023; 37:3946320231154988.

PMID: 36718110 PMC: 9893074. DOI: 10.1177/03946320231154988.


Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis.

Leodori G, Pellicano C, Basile V, Colalillo A, Navarini L, Gigante A J Pers Med. 2022; 12(10).

PMID: 36294874 PMC: 9604668. DOI: 10.3390/jpm12101737.


Non-Traditional Pro-Inflammatory and Pro-Atherosclerotic Risk Factors Related to Systemic Lupus Erythematosus.

Richter P, Cardoneanu A, Rezus C, Burlui A, Rezus E Int J Mol Sci. 2022; 23(20).

PMID: 36293458 PMC: 9604037. DOI: 10.3390/ijms232012604.


Adiponectin Deregulation in Systemic Autoimmune Rheumatic Diseases.

Brezovec N, Perdan-Pirkmajer K, cucnik S, Sodin-Semrl S, Varga J, Lakota K Int J Mol Sci. 2021; 22(8).

PMID: 33920997 PMC: 8071452. DOI: 10.3390/ijms22084095.


References
1.
Mattace-Raso F, van der Cammen T, Hofman A, van Popele N, Bos M, Schalekamp M . Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006; 113(5):657-63. DOI: 10.1161/CIRCULATIONAHA.105.555235. View

2.
Lau D, Dhillon B, Yan H, Szmitko P, Verma S . Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol. 2005; 288(5):H2031-41. DOI: 10.1152/ajpheart.01058.2004. View

3.
Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K . Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006; 116(7):1784-92. PMC: 1483172. DOI: 10.1172/JCI29126. View

4.
Bo S, Gambino R, Gentile L, Pagano G, Rosato R, Saracco G . High-normal blood pressure is associated with a cluster of cardiovascular and metabolic risk factors: a population-based study. J Hypertens. 2009; 27(1):102-8. DOI: 10.1097/hjh.0b013e328317a7bb. View

5.
Abu-Shakra M, Codish S, Zeller L, Wolak T, Sukenik S . Atherosclerotic cardiovascular disease in systemic lupus erythematosus: the Beer Sheva experience. Isr Med Assoc J. 2008; 10(1):43-4. View